Need Help?

The G2 gene expression signature and MYC overexpression are independent poor prognostic factors in childhood high-grade osteosarcoma

Key objective Are the prognostic transcriptomic G1/G2 gene expression signature, MYC overexpression, and MYC amplification replicable stratifying biomarkers for future clinical trials in high-grade osteosarcoma? Knowledge gathered In an unselected cohort, the G2 gene expression signature and MYC overexpression, but not MYC amplification, were independently associated with poor event-free and overall survival. Relevance Transcriptomic biomarkers may serve as stratifying factors that guide the management of patients with high-grade osteosarcoma. Current data underlines the importance of prospective validation of the G1/G2 signature and MYC overexpression in an international, multicenter, study.

Request Access

DUO:0000007
version: 2021-02-23

disease specific research

This data use permission indicates that use is allowed provided it is related to the specified disease.

ModifiersMONDO_0006517

Data Access Agreement of data controlled by the Data Access Commitee of the Princess Maxima Center for Pediatric Oncology

The Princess Maxima Center for pediatric oncology default access policy to enable re-production of research and re-use of data for scientific purposes. Please contact the DAC (EGAC00001001864) for the most up to date policies.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005312 Other
EGAS00001006723 Other
EGAS00001007099 Other
EGAS00001008073 Other
  • Changed sample subject id
  • Dataset Released

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00005299814 cram 7.3 GB
EGAF00005299824 cram 8.2 GB
EGAF00005299829 cram 7.1 GB
EGAF00005299854 cram 7.1 GB
EGAF00005299855 cram 7.5 GB
EGAF00005299930 cram 7.5 GB
EGAF00005488193 cram 9.4 GB
EGAF00007984716 cram 4.7 GB
EGAF00007984740 cram 6.5 GB
EGAF00007984767 cram 5.6 GB
EGAF00007984799 cram 6.2 GB
EGAF00007984813 cram 4.6 GB
EGAF00007984825 cram 7.9 GB
EGAF00008681971 cram 5.7 GB
EGAF00008681972 cram 10.6 GB
EGAF00008681975 cram 12.6 GB
EGAF00008681976 cram 10.4 GB
EGAF00008681978 cram 10.8 GB
EGAF00008681979 cram 5.9 GB
EGAF00008681980 cram 5.6 GB
EGAF00008681981 cram 8.1 GB
EGAF00008681982 cram 7.3 GB
EGAF00008681983 cram 4.4 GB
EGAF00008681984 cram 7.2 GB
EGAF00008681985 cram 7.6 GB
EGAF00008681986 cram 6.5 GB
EGAF00008681987 cram 5.9 GB
EGAF00008681988 cram 8.1 GB
EGAF00008681989 cram 7.5 GB
EGAF00008681990 cram 9.3 GB
EGAF00008681991 cram 7.3 GB
EGAF00008681992 cram 5.1 GB
EGAF00008681993 cram 6.4 GB
EGAF00008681995 cram 10.4 GB
EGAF00008681996 cram 5.4 GB
EGAF00008681997 cram 6.0 GB
EGAF00008681998 cram 8.9 GB
EGAF00008682000 cram 10.2 GB
EGAF00008682002 cram 5.2 GB
EGAF00008682004 cram 7.8 GB
EGAF00008682005 cram 5.3 GB
EGAF00008682008 cram 4.8 GB
EGAF00008682010 cram 6.2 GB
EGAF00008682012 cram 6.9 GB
EGAF00008682014 cram 14.9 GB
EGAF00008682016 cram 8.8 GB
EGAF00008682018 cram 7.1 GB
EGAF00008682020 cram 4.5 GB
EGAF00008682021 cram 7.8 GB
EGAF00008682023 cram 9.2 GB
EGAF00008682025 cram 5.2 GB
EGAF00008682027 cram 10.8 GB
EGAF00008682029 cram 9.0 GB
EGAF00008682031 cram 10.5 GB
EGAF00008682032 cram 16.3 GB
EGAF00008682034 cram 10.6 GB
EGAF00008682036 cram 10.4 GB
EGAF00008682038 cram 10.3 GB
EGAF00008682040 cram 4.8 GB
EGAF00008682042 cram 6.6 GB
EGAF00008682044 cram 9.1 GB
EGAF00008682046 cram 7.6 GB
EGAF00008682047 cram 8.5 GB
EGAF00008682048 cram 5.4 GB
EGAF00008682050 cram 6.4 GB
EGAF00008682052 cram 9.6 GB
EGAF00008682054 cram 9.2 GB
EGAF00008682055 cram 14.1 GB
68 Files (536.1 GB)